See more : Grupo Carso, S.A.B. de C.V. (GPOVY) Income Statement Analysis – Financial Results
Complete financial analysis of Sequent Scientific Limited (SEQUENT.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sequent Scientific Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- BigBen Interactive (0O0E.L) Income Statement Analysis – Financial Results
- Tianjin Teda Co., Ltd. (000652.SZ) Income Statement Analysis – Financial Results
- HM Inwest S.A. (HMI.WA) Income Statement Analysis – Financial Results
- Champion Bear Resources Ltd. (CBRSF) Income Statement Analysis – Financial Results
- BYD Company Limited (1211.HK) Income Statement Analysis – Financial Results
Sequent Scientific Limited (SEQUENT.NS)
About Sequent Scientific Limited
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.66B | 14.21B | 14.10B | 13.52B | 11.61B | 10.21B | 8.42B | 8.94B | 6.30B | 4.41B | 4.54B | 3.26B | 3.46B | 3.12B | 2.84B | 1.44B | 747.96M | 447.21M |
| Cost of Revenue | 7.85B | 8.34B | 8.44B | 7.37B | 6.38B | 5.74B | 4.83B | 4.84B | 3.54B | 2.59B | 2.85B | 2.12B | 1.92B | 1.62B | 1.28B | 665.45M | 545.58M | 303.64M |
| Gross Profit | 5.81B | 5.87B | 5.66B | 6.15B | 5.22B | 4.46B | 3.59B | 4.10B | 2.76B | 1.82B | 1.69B | 1.14B | 1.54B | 1.50B | 1.57B | 774.76M | 202.38M | 143.57M |
| Gross Profit Ratio | 42.53% | 41.32% | 40.12% | 45.52% | 44.99% | 43.71% | 42.62% | 45.86% | 43.78% | 41.20% | 37.30% | 34.97% | 44.47% | 48.02% | 55.12% | 53.79% | 27.06% | 32.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.85M | 124.50M | 88.56M | 96.87M | 115.37M | 65.82M | 0.00 | 0.00 | 0.00 | 0.00 | 12.80M | 4.69M |
| General & Administrative | 553.61M | 540.26M | 500.31M | 455.06M | 380.48M | 312.59M | 297.95M | 266.50M | 149.28M | 107.46M | 112.30M | 62.40M | 0.00 | 0.00 | 0.00 | 0.00 | 28.22M | 13.74M |
| Selling & Marketing | 285.88M | 281.33M | 276.76M | 217.38M | 237.79M | 141.34M | 177.85M | 157.93M | 142.78M | 115.38M | 61.00M | 42.72M | 0.00 | 0.00 | 0.00 | 0.00 | 22.54M | 5.97M |
| SG&A | 839.49M | 821.59M | 777.07M | 672.44M | 618.27M | 453.93M | 475.80M | 424.43M | 292.06M | 222.84M | 173.30M | 105.12M | 0.00 | 0.00 | 0.00 | 0.00 | 50.76M | 19.71M |
| Other Expenses | 4.69B | 63.90M | -51.74M | -30.79M | -83.07M | -60.99M | -44.18M | -114.67M | -53.23M | -2.59M | -37.42M | -24.76M | 1.29B | 238.02M | 956.40M | 850.65M | 77.99M | 4.80M |
| Operating Expenses | 5.53B | 6.14B | 4.98B | 4.35B | 3.84B | 3.43B | 2.98B | 3.56B | 2.49B | 1.80B | 1.64B | 1.35B | 1.29B | 1.18B | 956.40M | 850.65M | 141.55M | 29.20M |
| Cost & Expenses | 13.62B | 14.48B | 13.42B | 11.71B | 10.22B | 9.17B | 7.81B | 8.41B | 6.03B | 4.39B | 4.48B | 3.47B | 3.21B | 2.80B | 2.23B | 1.52B | 687.13M | 332.84M |
| Interest Income | 6.70M | 12.09M | 2.41M | 6.26M | 15.03M | 13.45M | 38.81M | 10.56M | 32.18M | 10.95M | 8.94M | 7.68M | 30.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 480.86M | 355.17M | 135.09M | 192.54M | 322.19M | 287.50M | 292.86M | 332.16M | 333.05M | 383.07M | 366.48M | 303.07M | 299.90M | 238.02M | 216.65M | 50.52M | 18.67M | 2.96M |
| Depreciation & Amortization | 615.40M | 556.93M | 510.85M | 505.98M | 506.22M | 419.20M | 413.43M | 400.73M | 482.31M | 329.35M | 325.97M | 286.07M | 229.81M | 206.90M | 239.10M | 64.79M | 29.98M | 13.79M |
| EBITDA | 549.80M | -464.48M | 1.20B | 2.12B | 1.80B | 1.34B | 980.57M | 540.22M | 638.77M | 114.11M | -382.81M | -106.97M | 475.58M | 431.29M | 850.70M | -11.10M | 85.73M | 126.57M |
| EBITDA Ratio | 4.02% | -0.08% | 8.38% | 16.31% | 15.38% | 12.66% | 11.81% | 10.77% | 10.70% | 6.90% | 4.23% | -1.57% | 13.75% | 16.74% | 29.91% | -0.77% | 11.46% | 28.66% |
| Operating Income | 370.21M | -153.46M | 579.62M | 1.69B | 1.25B | 1.06B | 667.08M | -14.22M | -212.91M | -699.16M | -1.10B | -741.21M | 245.77M | 314.96M | 611.60M | -75.89M | 60.83M | 114.37M |
| Operating Income Ratio | 2.71% | -1.08% | 4.11% | 12.48% | 10.79% | 10.41% | 7.92% | -0.16% | -3.38% | -15.87% | -24.22% | -22.73% | 7.11% | 10.11% | 21.50% | -5.27% | 8.13% | 25.57% |
| Total Other Income/Expenses | -916.67M | -1.38B | 177.92M | -3.17B | -517.41M | -441.96M | -369.64M | -129.69M | 33.17M | -457.75M | -1.30B | -270.90M | -299.90M | -280.07M | -216.65M | -50.52M | -23.75M | -2.95M |
| Income Before Tax | -546.46M | -1.38B | 533.86M | 1.37B | 940.75M | 588.84M | 236.45M | 6.38M | -169.64M | -633.19M | -1.10B | -727.50M | -54.13M | 34.89M | 394.95M | -126.41M | 37.08M | 111.42M |
| Income Before Tax Ratio | -4.00% | -9.69% | 3.79% | 10.11% | 8.11% | 5.77% | 2.81% | 0.07% | -2.69% | -14.37% | -24.22% | -22.31% | -1.57% | 1.12% | 13.88% | -8.78% | 4.96% | 24.91% |
| Income Tax Expense | -250.33M | -156.81M | 83.26M | 321.77M | 120.29M | 20.07M | 134.57M | -4.13M | 28.21M | 33.90M | 5.79M | -80.58M | -39.54M | 75.13M | 85.26M | 20.18M | 11.86M | 58.63M |
| Net Income | -358.69M | -1.21B | 409.55M | 954.42M | 699.05M | 486.60M | 4.22B | -138.24M | -221.56M | -107.38M | -1.10B | -646.94M | -13.99M | -1.76M | 374.17M | -146.59M | 25.22M | 85.75M |
| Net Income Ratio | -2.63% | -8.53% | 2.90% | 7.06% | 6.02% | 4.77% | 50.07% | -1.55% | -3.52% | -2.44% | -24.35% | -19.84% | -0.40% | -0.06% | 13.15% | -10.18% | 3.37% | 19.17% |
| EPS | -1.44 | -4.88 | 1.67 | 3.87 | 2.87 | 2.00 | 17.40 | -0.58 | -1.06 | -0.75 | -8.55 | -5.70 | -0.13 | -0.02 | 3.52 | -2.64 | 0.51 | 1.52 |
| EPS Diluted | -1.44 | -4.84 | 1.65 | 3.85 | 2.85 | 1.99 | 17.28 | -0.57 | -1.04 | -0.75 | -8.55 | -5.70 | -0.13 | -0.02 | 3.52 | -2.64 | 0.51 | 1.52 |
| Weighted Avg Shares Out | 249.09M | 248.47M | 247.41M | 246.88M | 243.44M | 242.79M | 242.29M | 239.31M | 208.49M | 143.08M | 129.19M | 113.48M | 109.68M | 109.68M | 106.18M | 55.43M | 49.00M | 33.33M |
| Weighted Avg Shares Out (Dil) | 249.09M | 250.11M | 250.73M | 247.87M | 245.31M | 243.99M | 243.94M | 241.00M | 212.17M | 143.08M | 129.19M | 113.48M | 109.68M | 109.68M | 106.18M | 55.43M | 49.00M | 33.33M |
Source: https://incomestatements.info
Category: Stock Reports